Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 2681 - 2688 of 12099 results

CMS Proposes Changes to Medicare Advantage Regulations: Network Adequacy, Beneficiary Access, MLR Reporting, and MOOP

January 19, 2022| Blog| Viewpoint

FTC, DOJ Launch Proceeding to Revise Antitrust Merger Guidelines

January 19, 2022| Blog| Viewpoint

Entire Market Value Rule Strikes Again in WDTX

January 19, 2022| Blog| Viewpoint

Legal ESG Summit Resources

January 19, 2022| Video| Viewpoint

Nurturing a Community-Based Approach to Food Access

January 18, 2022| Article| Viewpoint

U.S. Department of Homeland Security Extends Flexibilities for Immigration Processes in Response to COVID-19, But Uncertainty Lies on the Other Side of the Pandemic

January 18, 2022| Blog| Viewpoint

Co-Owner of Clinical Trial Company Pleads Guilty to Obstruction of Justice in Connection with Falsification of Clinical Trial Data

January 18, 2022| Blog| Viewpoint

Preparation for 2021 Fiscal Year-End SEC Filings and 2022 Annual Shareholder Meetings

January 18, 2022| Advisory| Viewpoint

News & Press Releases

Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE

August 15, 2025

Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.

Eleven Mintz Attorneys Named to 2025 IAM Strategy 300 List of Leading IP Strategists

August 14, 2025

Mintz announces that eleven of its attorneys have been named to the 2025 IAM Strategy 300: The World's Leading IP Strategists list, which recognizes individuals for their trailblazing work in developing and implementing strategies that maximize the value of intellectual property portfolios.

ESG-Focused Activism Persists Despite Proxy Curbs

August 12, 2025

Law360 published an article written by Mintz Members Jacob Hupart, Ellen Shapiro, and Associate Will McKitterick about the role ESG considerations continue to play in shareholder activism and proxy battles. The article also examines how recent regulatory and political developments have raised the bar for ESG-related proposals, influencing both strategy and outcomes.

View all News and Press Releases